Orthogonal Clickable Iron Oxide Nanoparticle Platform for Targeting, Imaging, and On-Demand Release

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Developing advanced nanomaterials is crucial for applications in drug delivery, targeted therapy, and medical imaging.
• Iron oxide nanoparticles offer unique magnetic properties suitable for various biomedical applications.
• Orthogonal functionalization allows for precise control over nanoparticle surface chemistry and functionality.

Purpose of the Study:

• To develop a versatile iron oxide nanoparticle platform that can be orthogonally functionalized for diverse biomedical applications.
• To demonstrate the utility of these nanoparticles for drug delivery, targeted cancer therapy, and imaging.
• To enable on-demand drug release using magnetic hyperthermia.

Main Methods:

• Orthogonal functionalization of iron oxide nanoparticles with maleimide and alkyne groups via isocyanate-containing ligands.
• Surface modification using Diels-Alder and azide-alkyne cycloaddition reactions.
• Loading a fluorophore as a drug model and biotin as a targeting ligand.
• Utilizing magnetic hyperthermia to trigger drug release.
• In vitro cancer cell targeting studies analyzed by magnetic resonance imaging.

Main Results:

• Successful orthogonal functionalization of iron oxide nanoparticles with high surface coverage of maleimide and alkyne groups.
• Demonstrated proof-of-principle for loading a drug model (fluorophore) and a targeting ligand (biotin).
• Achieved on-demand release of loaded molecules triggered by magnetic hyperthermia.
• Confirmed in vitro targeting of cancer cells using magnetic resonance imaging.

Conclusions:

• The developed iron oxide nanoparticle platform is highly versatile and amenable to orthogonal functionalization.
• This platform enables targeted drug delivery, controlled release via magnetic hyperthermia, and cancer cell imaging.
• These findings highlight the potential of these functionalized nanomaterials for advanced therapeutic and diagnostic applications in oncology.